Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Deals
|
M&A
|
Financials
|
Strategy
|
Lifecycle Management
|
Legal
|
NeoStem raises $16.5M as it continues to shift its focus to cell therapy
21 July 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
Not a subscriber?
Subscribe to Scrip
Request a FREE Trial
RELATED CONTENT
NEWS
Scrip News
AMAG, Allos to merge – but will it really bring sales synergies for Feraheme, Folotyn?
Achillion raising $56.6 million to advance hepatitis C candidates
UK value-based price negotiations start in 2012
BioSante to begin Phase I trial of melanoma vaccine at Johns Hopkins
Other Informa News
NeoStem raises $16.5M as it continues to shift its focus to cell therapy
The feeling’s mutual: Corin, Stryker end US Cormet distribution partnership
COMMENT
Scrip Comment
Blade of truth lacerates the a web of intrigue
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads